Technical University of Munich

tum.de

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

312

Active

48

Phase 3

13

Total enrollment

429,698

Pipeline matrix

Showing 6 of 6 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Comirnaty Injectable Product1
Sodium Chloride 0.9% Inj1
Fasudil hydrochloride1
RAVICTI 1.1 g/ml1
Experimental: Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]1
Propofol4

Next readouts

  • 2024-09-10
  • 2025-09-01
  • 2026-03-30
  • 2026-09-30
  • 2027-10

Top conditions

  • Obesity6
  • Schizophrenia6
  • Breast Cancer6
  • Critical Care5
  • Colon Adenoma5
  • Anesthesia5
  • Critical Illness5
  • Schizoaffective Disorder4

Frequently asked questions about Technical University of Munich

How many clinical trials does Technical University of Munich have on ClinicalTrials.gov?
Technical University of Munich is listed as the lead sponsor on 312 clinical trials in ClinicalTrials.gov, 48 of which are currently active (recruiting, enrolling, or ongoing).
How many of Technical University of Munich's trials are in Phase 3?
13 of Technical University of Munich's trials are in Phase 3, spread across 6 active drug programs.
What therapeutic areas does Technical University of Munich focus on?
Technical University of Munich's most-studied conditions on ClinicalTrials.gov are Obesity, Schizophrenia, Breast Cancer, Critical Care, Colon Adenoma.
When are Technical University of Munich's next clinical trial readouts?
Technical University of Munich has 5 upcoming primary-completion readouts tracked here; the soonest is “EEG-fMRI Experiments During Anesthesia Induction With Propofol”, expected around 2024-09-10.